Get the Daily Brief
Latest Biotech News
Urban Morphology Influences Compound Natural Risks in US
A multiscale US study published in npj Urban Sustainability demonstrates how variations in urban form distinctly shape the amplification of compound natural hazards like heatwaves, flooding, and...
AI-Generated Podcasts Enhance Scientific Communication
A study led by Professor Philip Moons at the University of Leuven demonstrated the capabilities of AI in producing high-quality podcasts that summarize scientific research, using Google...
ASCO 2025 Spotlights Bispecifics and Cancer Drug Innovations
The 2025 ASCO meeting in Chicago highlighted significant cancer therapy developments, including Bristol Myers Squibb’s multibillion-dollar partnership focusing on bispecific antibodies. The...
Oral Health Economic Burden Calls for Reformed Approaches
Oral diseases impose nearly $140 billion in annual costs on the US healthcare system, a figure that dramatically exceeds many chronic conditions. Commentary suggests that treating tooth decay with...
Science Collaboration Reinforces Breakthroughs Across Disciplines
A reflective analysis underscores the paramount role of collaboration in advancing scientific breakthroughs, challenging the myth of solitary genius. Examples include the Polymath Project’s rapid...
Upcoming LSX USA Congress to Convene Biotech Leaders
The LSX USA Congress, scheduled for mid-September 2025 in Boston, will bring together senior executives, investors, and biotech innovators from across the US. The event promises dynamic networking...
Sarepta gene therapy suspension after second DMD patient dies
Sarepta Therapeutics has halted shipments of its FDA-approved Duchenne muscular dystrophy gene therapy Elevidys for non-ambulatory patients following the second recent death from acute liver...
Bristol Myers Squibb strategic hire from Wall Street
Bristol Myers Squibb appointed Chris Shibutani, M.D., formerly a senior biotech analyst at Goldman Sachs, as EVP and chief strategy officer. Shibutani combines clinical experience as an...
Innovative magnetic soft millirobot with sensing capabilities
A research team led by W. Zeng and colleagues has developed a millimeter-scale magnetic soft robot capable of simultaneous locomotion and environmental sensing. Published in npj Flexible...
Parkinson’s disease insights from perivascular fluid and nerve fibers
Recent studies underscore novel biomarkers and pathological features in Parkinson’s disease and atypical parkinsonism. One cohort study, published in npj Parkinson’s Disease, identified...
Advances in solid-state nanopore sensors for DNA sequencing
Researchers at the University of Illinois Urbana-Champaign engineered a novel solid-state nanopore platform using 2D materials, advancing label-free single-biomolecule detection technology....
AI-generated podcasts redefine science communication
A study led by Professor Philip Moons demonstrated the capability of AI, using Google NotebookLM, to produce podcasts summarizing scientific research effectively. The AI-generated content received...
European Moveo project launches smart transport innovations
The MOVEO project officially launched in Málaga, Spain, brings together 16 partners from nine countries to develop sustainable, integrated transport solutions across Europe. Funded by Horizon...
Pharma reforms and challenges in US budget bill
The extensive US budget bill under Senate consideration includes significant changes impacting pharma, including reform proposals for the Inflation Reduction Act’s Medicare drug price negotiation...
23andMe sold to Anne Wojcicki's nonprofit amid bidding war
Genetic testing firm 23andMe agreed to be acquired by a nonprofit led by co-founder Anne Wojcicki for $305 million, prevailing in a final bidding round over Regeneron. This transaction concludes a...
Emerging PD-1 x IL-2 antibody fusions in cancer therapy
Innovent Biologics advances their PD-1 × IL-2 antibody fusion IBI363 into registrational studies after demonstrating Phase I/II efficacy across three cold tumor types. This bispecific approach...
Sarepta Halts Duchenne Gene Therapy After Second Patient Death
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second fatality caused by acute liver failure. Both...
Anne Wojcicki's Nonprofit Wins 23andMe Asset Auction at $305M
Anne Wojcicki, co-founder and ex-CEO of 23andMe, has prevailed in a bankruptcy auction for the company's assets by bidding $305 million through her nonprofit TTAM Research Institute. This offer...
FDA Approves Pembrolizumab for Resectable Head and Neck Cancer
The FDA has approved pembrolizumab, an immune checkpoint inhibitor, for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1 (CPS≥1). Approval was based...
Breakthroughs in Parkinson’s Disease Biomarkers and Pathology
Recent studies have uncovered novel insights into Parkinson’s disease pathology and progression. Researchers identified changes in cutaneous nerve fibers linked to Parkinson’s and atypical...